(Q30357294)

20 June 2017

title

Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations. (English)

1 reference

20 June 2017

0 references

Robert L Atmar

1 reference

20 June 2017

Wendy A Keitel

1 reference

20 June 2017

Jacqueline M Katz

1 reference

20 June 2017

Shital M Patel

1 reference

20 June 2017

Dewei She

1 reference

20 June 2017

Hana El Sahly

1 reference

20 June 2017

Justine Pompey

1 reference

20 June 2017

Thomas R Cate

1 reference

20 June 2017

Robert B Couch

1 reference

20 June 2017

language of work or name

English

0 references

publication date

25 September 2006

1 reference

Clinical Infectious Diseases

20 June 2017

published in

1 reference

20 June 2017

1 reference

20 June 2017

1 reference

20 June 2017

page(s)

1135-1142

1 reference

Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003.

20 June 2017

cites work

1 reference

Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands

21 January 2018

1 reference

Avian influenza A (H5N1) in 10 patients in Vietnam

21 January 2018

1 reference

Confronting the avian influenza threat: vaccine development for a potential pandemic.

21 January 2018

1 reference

Continuing evolution of H9N2 influenza viruses in Southeastern China.

21 January 2018

1 reference

Human infection with influenza H9N2.

21 January 2018

1 reference

H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity

21 January 2018

1 reference

Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial

21 January 2018

1 reference

Vaccination strategies for an influenza pandemic.

21 January 2018

1 reference

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

21 January 2018

1 reference

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

21 January 2018

1 reference

Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines

21 January 2018

1 reference

Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

21 January 2018

1 reference

Immunity to influenza A H9N2 viruses induced by infection and vaccination

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/508174

1 reference

20 June 2017

1 reference